NDC 0006-5029

VERQUVO

Vericiguat

VERQUVO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Vericiguat.

Product ID0006-5029_15049ae3-29b9-496a-bf12-350978af10bb
NDC0006-5029
Product TypeHuman Prescription Drug
Proprietary NameVERQUVO
Generic NameVericiguat
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-02-01
Marketing CategoryNDA / NDA
Application NumberNDA214377
Labeler NameMerck Sharp & Dohme Corp.
Substance NameVERICIGUAT
Active Ingredient Strength5 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0006-5029-01

14 TABLET, FILM COATED in 1 BOTTLE (0006-5029-01)
Marketing Start Date2021-02-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "VERQUVO" or generic name "Vericiguat"

NDCBrand NameGeneric Name
0006-5028VERQUVOvericiguat
0006-5029VERQUVOvericiguat
0006-5030VERQUVOvericiguat

Trademark Results [VERQUVO]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VERQUVO
VERQUVO
90764015 not registered Live/Pending
Bayer Aktiengesellschaft
2021-06-09
VERQUVO
VERQUVO
87952816 5810492 Live/Registered
Bayer Aktiengesellschaft
2018-06-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.